Prolonged cell cycle arrest by the CDK4/6 antagonist narazaciclib restores ibrutinib response in preclinical models of BTKi‐resistant mantle cell lymphoma
Núria Profitós-Pelejà, Marcelo Lima Ribeiro, J. Parra, Miranda Fernández-Serrano, Pau Marin-Escudero, Adar Makovski-Silverstein, Stephen C. Cosenza, Manel Esteller, Gaël Roué (2023). Prolonged cell cycle arrest by the CDK4/6 antagonist narazaciclib restores ibrutinib response in preclinical models of BTKi‐resistant mantle cell lymphoma. , 41(S2), DOI: https://doi.org/10.1002/hon.3164_414.
